Listed

Grace Therapeutics, Inc.: Form 20-F for the period ended Mar 31, 2019

Filed with the SEC on Jun 26, 2019 and accepted by EDGAR at Jun 26, 2019, 08:12 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating cash flow12 months2018-04-01 to 2019-03-31−CAD 32.5mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2018-04-01 to 2019-03-31CAD 700.0kifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Shares outstandingAt period end2019-03-3178,132,734 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001171843-19-004174. Last ingested by Listed: Nov 14, 2026, 23:10 ET. Listed shows no prices and gives no investment advice.